APH ALLIANCE PHARMA PLC ORD 1P

ALLIANCE PHARMA Currency GBX

Income Statement (£ m)	31-Dec-12	31-Dec-11	31-Dec-10	31-Dec-09	31-Dec-08
Continuing Operations
Revenue	44.90	45.96	49.88	31.24	21.76
Operating Profit/(Loss)	12.32	12.34	16.97	8.43	6.37
Net Interest	1.52	1.57	2.20	2.70	3.09
Profit Before Tax	10.81	10.71	12.87	5.74	2.42
Profit After Tax	8.69	8.64	8.95	4.11	2.51
Discontinued Operations
Profit After Tax	0.00	0.00	0.00	0.00	0.00
PROFIT FOR THE PERIOD	8.69	8.64	8.95	4.11	2.51
Attributable to:
Minority Interests	0.00	0.00	0.00	0.00	0.00
Equity Holders of Parent Company	8.69	8.64	8.95	4.11	2.51

Continuing EPS
Earnings per Share - Basic	3.61p	3.62p	3.96p	2.37p	1.55p
Earnings per Share - Diluted	3.40p	3.39p	3.64p	2.14p	1.49p
Earnings per Share - Adjusted	3.61p	3.62p	5.07p	3.55p	1.17p
Continuing and Discontinued EPS
Earnings per Share - Basic	3.61p	3.62p	3.96p	2.37p	1.55p
Earnings per Share - Diluted	3.40p	3.39p	3.64p	2.14p	1.49p
Earnings per Share - Adjusted	3.61p	3.62p	5.07p	3.55p	1.17p

Dividend per Share	0.75p	0.57p	0.30p	0.00p	0.00p

Balance Sheet (£ m)	31-Dec-12	31-Dec-11	31-Dec-10	31-Dec-09	31-Dec-08
Assets
Non-Current Assets
Property, Plant & Equipment	0.56	0.77	0.89	0.13	0.16
Intangible Assets	79.89	66.13	60.29	44.94	39.95
Investment Properties	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00
Other Financial Assets	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.07
	80.45	66.90	61.18	45.07	40.18
Current Assets
Inventories	5.39	5.65	4.54	2.97	2.27
Trade & Other Receivables	10.15	8.66	9.69	7.66	6.38
Cash at Bank & in Hand	4.63	1.08	1.99	1.10	0.00
Current Asset Investments	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.00	0.00	0.00	0.00	0.00
	20.17	15.39	16.22	11.73	8.65

Total Assets	100.63	82.29	77.40	56.80	48.83

Liabilities
Current Liabilities
Borrowings	-10.44	-4.25	-4.00	-3.80	-4.75
Other Current Liabilities	-11.61	-9.61	-12.98	-7.65	-6.40
	-22.05	-13.86	-16.98	-11.45	-11.14

Net Current Assets	-1.87	1.53	-0.76	0.29	-2.49

Non-Current Liabilities
Borrowings	-20.23	-19.69	-19.82	-26.34	-27.78
Provisions	-6.49	-4.57	-4.44	-1.45	-0.03
Other Non-Current Liabilities	-0.02	-0.04	-0.07	-0.93	-1.11
	-26.73	-24.30	-24.34	-28.72	-28.93

Other Liabilities	n/a	n/a	n/a	n/a	n/a
Total Liabilities	-48.78	-38.16	-41.32	-40.17	-40.07

Net Assets	51.85	44.13	36.08	16.63	8.77

Capital & Reserves
Share Capital	2.43	2.40	2.36	1.93	1.62
Share Premium Account	25.30	24.87	24.33	14.67	11.28
Other Reserves	0.46	0.09	-0.11	-1.19	-1.23
Retained Earnings	23.66	16.77	9.49	1.21	-2.90
Shareholders Funds	51.85	44.13	36.08	16.63	8.77

Minority Interests/Other Equity	0.00	0.00	0.00	0.00	0.00
Total Equity	51.85	44.13	36.08	16.63	8.77

Ratios - based on IFRS	31-Dec-12	31-Dec-11	31-Dec-10	31-Dec-09	31-Dec-08
Continuing Operations
PE Ratio - Adjusted	8.80	8.53	6.11	7.46	2.24
PEG - Adjusted	-31.43	-0.30	0.14	0.04	0.01
Earnings per Share Growth - Adjusted	-0.28%	-28.60%	42.82%	203.42%	408.70%
Dividend Cover	4.81	6.35	16.90	n/a	n/a
Revenue Per Share	18.64p	19.26p	22.06p	18.04p	13.43p
Pre-Tax Profit per Share	4.49p	4.49p	5.69p	3.31p	1.50p
Operating Margin	27.45%	26.72%	30.21%	27.00%	25.24%
Return on Capital Employed	135.28%	188.74%	371.21%	256.85%	401.16%

Continuing & Discontinued Operations
Dividend Yield	2.36%	1.85%	0.97%	0.00%	0.00%
Dividend per Share Growth	31.58%	90.00%	n/a	n/a	n/a
Net Asset Value per Share (exc. Intangibles)	-11.54p	-9.19p	-10.25p	-14.64p	-19.24p
Net Gearing	50.20%	51.79%	60.51%	174.59%	371.03%

Data is provided by Morningstar

ALLIANCE PHARMA - Fundamentals